Another Yaz thrombosis lawsuit has been filed over Bayer’s oral contraceptive, Yaz (drospirenone, ethinyl estradiol). The lawsuit was originally filed April 30, 2013 in the U.S. District Court, Northern District of New York (Syracuse). On August 19, 2013, the case was transferred to the Southern District of Illinois for inclusion in the multidistrict litigation (Yasmin and Yaz Marketing, Sales Practices, and Products Liability Litigation). An MDL is a federal procedure in which a number of complex cases are combined for pre-trial processing to minimize strains on the court and duplicative processes.
Click here for the full article from InjuryLawyerNews.com.